Acute Kidney Injury, Anxiety, COVID-19, Depressive Symptoms
Conditions
Brief summary
The frequency of psychological conditions in recovered COVID-19 patients with Acute Kidney Injury (AKI) and their informal primary caregivers (IPC) is unknown; as well as the effects of psychological therapy in this population. The present study was initiated to determine the effectiveness of a brief remote psychological intervention (BRPI) to reduce anxious and depressive symptoms in survivors of AKI. The investigator designed a single-case experimental design A-B with prospective follow-up. We used the Patient Health Questionnaire-9 (PHQ-9) and the General Anxiety Disorder Scale-7 (GAD-7) to screen for depressive and anxiety symptoms, one week later after hospital discharge. Those with moderate or severe symptoms received cognitive behavioral therapy (CBT) and were evaluated over time with the instruments and daily self-report of symptoms. The statistical analysis was conducted using statistical software.
Interventions
BEHAVIORALCognitive behavioral therapy
The investigator adapted the manual of psychological intervention based on Cognitive Behavioral Therapy (CBT) which previously was validated in patients with chronic kidney disease. Patients received CBT using a model of six modules, with a time of 60 minutes for each weekly session. For each module, a skill acquisition criterion was used, to know if the participants were putting the techniques into practice in their daily lives and to know if it was pertinent to move on to the next module. Modules were adapted to the needs of each participant. In consequence, the number of sessions was different for each patient. All participants had a follow-up session one month after they finished the psychological therapy. Additionally, a daily self-record of symptoms perception and a short questionnaire on the usefulness of each technique used were sent daily to the participants via a phone text message.
Sponsors
Jesus Rivero, MD
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No
Inclusion criteria
* Survivors of severe COVID-19 who had AKI during hospitalization * Informal primary caregivers
Exclusion criteria
* They did not accept to participate in the study * They did not answer three attempted phone calls or text messages making it impossible to complete the intervention.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Anxious symptoms score for identifying changes in psychological behavior before and after to brief remote psychological intervention. | From the date of one week later after hospital discharge at the hospital until the date of the end intervention, in average one month | Psychological behavior changes were evaluated by the anxious symptoms score (mild, moderate, and severe) using General Anxiety Disorder Scale-7 (GAD-7). |
| Depressive symptoms score for identifying changes in psychological behavior before and after to brief remote psychological intervention. | From the date of one week later after hospital discharge at the hospital until the date of the end intervention, in average one month | Psychological behavior changes were evaluated by the depressive symptoms score (mild, moderate, and severe) using the Patient Health Questionnaire-9 (PHQ-9). |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| General perception scale for identifying the utility of each technique used for the management of psychological symptoms. | From the date of one week later after hospital discharge at the hospital until the date of the end intervention, in average one month | The utility of each technique used for the management of psychological symptoms was evaluated by the general perception scale using a short questionnaire with daily self-record of symptoms perception (0-10 scale). |
Countries
Mexico
Outcome results
None listed